(Q47436544)

English

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

ovarian carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Susanne Krüger Kjaer

3

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

author name string

Estrid V S Høgdall

1

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

Andy Ryan

2

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

Jan Blaakaer

4

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

Lise Christensen

5

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

Johannes E Bock

6

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

Eva Glud

7

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

Ian J Jacobs

8

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

Claus K Høgdall

9

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

100

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

11

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

2387-2395

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

Heterogeneity of ovarian cancer: relationships among histological group, stage of disease, tumor markers, patient characteristics, and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

All in the (cancer) family

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

Xp22.2-3 loss of heterozygosity is associated with germline BRCA1 mutation in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

Plasma tetranectin and ovarian neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

RESPONSE: Re: Association Between Nonrandom X-Chromosome Inactivation and BRCA1 Mutation in Germline DNA of Patients With Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

21 January 2018

The treatment of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of heterozygosity in P53, BRCA1, and estrogen receptor genes and correlation to expression of p53 protein in ovarian epithelial tumors of different cell types and biological behavior

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

The genetic analysis of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrin degradation products and ovarian tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

The fibrinolytic system. A key to tumor metastasis?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathways of coagulation/fibrinolysis activation in malignancy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutation, ageing, and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20213

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20213

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/15160342

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47436544&oldid=2157741835"